ArriVent BioPharma, Inc. AVBP
NASDAQ · United States · Health Technology
$29.99-0.29 (-0.96%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -1.05 | -0.99 | -6.3% | $0 | — | -4.4%$31.39→$30.00 |
| Q1 2026 | 2026-05-11 | -0.96 | -0.88 | -9.1% | — | — | -1.8%$29.50→$28.97 |
| Q4 2025 | 2026-03-05 | -0.78 | -0.85 | +8.2% | — | — | -11.8%$26.56→$23.43 |
| Q3 2025 | 2025-11-10 | -0.83 | -0.78 | -6.4% | — | — | +7.4%$18.05→$19.38 |
| Q2 2025 | 2025-08-11 | -0.90 | -0.71 | -26.8% | — | — | — |
| Q4 2024 | 2025-03-03 | -0.61 | -0.78 | +21.8% | — | — | — |
| Q4 2023 | 2024-03-28 | -30.76 | -0.65 | -4,632.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.